Star Combo Pharma Limited
Prices may be delayed up to 20 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| S66.AX | NAII | JWEL.TO | UPC | PHARMAID.BO | PHN.MI | |
|---|---|---|---|---|---|---|
| Market cap | 22.96M | 6.89M | 1.89B | 7.39M | 1.03B | 706.65M |
| P/E (TTM) | — | — | 24.8 | — | — | 34.5 |
| Forward P/E | — | — | 18.4 | — | — | 23.6 |
| Price/book | 0.6 | 0.1 | 3.7 | 0.0 | 2.2 | 10.2 |
| Dividend yield | 1.69% | — | 2.19% | — | — | 1.66% |
| 1-year change | −18.60% | −62.20% | +31.60% | −62.88% | −37.65% | +64.96% |
| Today | −2.86% | +3.77% | +0.07% | −1.34% | −0.82% | +1.79% |
The closest companies by business and industry (Household & Personal Products). Prices may be delayed up to 20 min.
Latest news
All S66.AX news ›Star Combo Pharma Limited (ASX:S66): Manufacturing Operations and FY26 Financial Performance
How the Manufacturing Model Works The group manufactures products for third-party customers and maintains its own brands, including Costar, Living Healthy, Amax and J&K. The product mix encompasses supplements and skincare, rather than…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- kalkine.com.au1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 1 articles, not a forecast.